FlexNow | Formerly BSP 201

FlexNow | Formerly BSP 201 | BSP Pharma
The Next Generation in Inflammation ManagementBSP-201 with High Triterpene Shea Nut Extract Inflammation / Cytokine Management
 
 
BSP-201 addresses the root cause of inflammation-based conditions.  Pharmaceutical - standard clinical research proves BSP-201 down-regulates cytokine production:
 
ºTNF-a mean reduction:  24%*
ºIL-6 mean reduction:  31%*
ºCRP mean reduction:  21%*
 
Allow the body to heal naturally and effectively by managing inflammation:  Joint Care, Cardiovascular Management, Gastrointestinal Health, Neurological Wellness, et al.
Patented, all-natural and available exclusively from BSP Pharma Inc.

Proven
Over 30 clinical trials and studies, including human, double-blind, placebo-controlled trials prove BSP-201 significantly reduces inflammation by regulating cytokine production. To date, a majority of the clinical research on BSP-201 has focused on joint care health, with statistically significant and clinically meaningful results.

Safe & All Natural
No side effects, No allergies, No contradications.
In over 30 clinical trials and studies, and across tens of thousands of consumers using the product, BSP-201 has produced no adverse effects.

One of only seven products accepted by the FDA in 2004, BSP-201 provided a clinical record of efficacy and safety which exceeded the stringent requirements of the FDA.
 
As well, the raw material used to produce BSP-201 has been used as a food and food ingredient in Europe for centuries – shea oil and butter are common ingredients in both baked goods and chocolate production.
 
By the way, if you have a nut allergy, don’t worry. The “shea nut” is actually the pit of the shea fruit, and is not really a nut.


Sustainable
BSP-201 is wild-crafted, harvested, and processed in concert with the UN Development Programme, preserving the shea nut tree and helping West African communities establish economic independence.